iifl-logo-icon 1

Norris Medicines Ltd Cash Flow Statement

22.2
(-1.99%)
Feb 7, 2025|03:31:00 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Norris Medicines FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

-3.99

-3.68

-3.18

-1.18

Depreciation

-0.66

-0.72

-0.7

-0.64

Tax paid

-0.96

0.83

0.67

0.41

Working capital

-5.79

5.62

-2.44

-2.57

Other operating items

Operating

-11.41

2.05

-5.66

-3.98

Capital expenditure

0.08

0.37

-0.44

2.22

Free cash flow

-11.32

2.42

-6.1

-1.76

Equity raised

-24.78

-17.42

-10.72

-9.19

Investing

0

0

0

0

Financing

27.56

25.59

15.12

15.04

Dividends paid

0

0

0

0

Net in cash

-8.55

10.58

-1.7

4.08

Norris Medicines : related Articles

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.